Department News

Rare Disease Research to Be Showcased at Virtual Event
2/15/23
Researchers at the University at Buffalo are hard at work studying rare diseases and caring for the many patients suffering from them. UB will hold an event recognizing rare disease patients, their clinicians and the researchers working to discover causes — and ultimately cures — for these conditions.
Surviving Rare Stroke Leaves Powerful Lessons for Student
2/6/23
When she talks about why she wants to be a doctor, Sydney Johnson tells the story of how she and her twin sister came into this world. Sydney was supposed to be delivered by C-section, since she was in a breech position, but somehow, regrettably, that didn’t happen. The physician decided to deliver both babies naturally. It was a decision that Sydney and her mother nearly paid for with their lives.
Andreadis and Feltri are Named AAAS Fellows
2/2/23
University at Buffalo faculty members Stelios Andreadis, PhD, and M. Laura Feltri, MD, have been elected fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals.
Student-Run Research Day Highlights Graduate Students’ Work
1/18/23
From the time she heard about the inaugural Graduate Student Research Day, Taylor Wicks was thrilled with the opportunity to showcase her work.
Low-Dose Lithium Treatment for Long COVID Explored
1/10/23
Adults experiencing long COVID may be interested in a new University at Buffalo clinical trial that is testing low-dose lithium as a potential treatment.
Brashear Elected to AAMC Council of Deans Board
12/6/22
Allison Brashear, MD, MBA, UB’s vice president for health sciences and dean of the Jacobs School of Medicine and Biomedical Sciences, has been elected to the Association of American Medical Colleges (AAMC) Council of Deans Administrative Board.
Trials Offer New Approach to Treating Myasthenia Gravis
12/6/22
Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of the Department of Neurology, is involved in trials of FcRn (neonatal FC receptor) antagonists that offers a new approach to treating myasthenia gravis (MG).
Guidelines for MS Clinicians: Talking About Brain Atrophy
11/14/22
A team of Jacobs School of Medicine and Biomedical Sciences researchers has published a paper that provides novel guidelines for clinicians when discussing brain atrophy with their multiple sclerosis (MS) patients.
NIH Grant Aims to Boost Newborn Screening Accuracy
11/6/22
“Your baby has a genetic disease.” It’s one of the most terrifying things that new parents can hear. Yet it frequently turns out not to be true because, while newborn screening is extremely accurate for many common conditions, screening accuracy rates for rare — even fatal — conditions can be abysmal, according to genetics specialists.
18 Medical School Awardees Honored for Excellence
10/27/22
Fifteen faculty members and three staff members from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievements and service at the 19th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.

Next> <Previous